리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 12월
페이지 정보:영문 587 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 감염 관리 시장은 2030년까지 834억 달러에 이를 전망
감염 관리 세계 시장은 2024년에 563억 달러로 추정되었고, 2024-2030년의 분석 기간에 CAGR 6.8%로 성장하여 2030년까지 834억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석 대상이 된 부문 중 하나인 방호 배리어는 7.7%의 CAGR을 보이고, 분석 기간 종료까지 348억 달러에 이를 것으로 예측됩니다. 멸균 제품 및 서비스 부문의 성장률은 분석 기간에 7.0%의 CAGR을 보일 전망입니다.
미국 시장은 153억 달러로 추정되는 한편, 중국은 8.0%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다
미국의 감염 관리 시장은 2024년에 153억 달러로 추정되고 있습니다. 세계 제2위 경제 규모를 자랑하는 중국은 2024-2030년의 분석 기간에 CAGR 8.0%로 성장을 지속하여, 2030년까지 129억 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장 분석으로서는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중에 5.4%, 6.7%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 유럽에서는 독일이 약 6.2%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.
세계의 감염 관리 시장 - 주요 동향과 성장요인 개요
오늘날 감염 관리의 범위와 중요성을 정의하는 것은 무엇일까요?
감염관리는 의료시설과 지역사회에서 감염 확산을 방지하거나 차단하는 것을 목적으로 하는 의료분야의 중요한 전문 분야입니다. 이 분야는 감염 위험을 최소화하기 위해 사용되는 다양한 관행, 프로세스, 절차를 포괄합니다. 환자와 의료진 모두를 보호하기 위해 소독 방법, 멸균 절차, 위생 관리 관행이 사용됩니다. 감염관리는 병원뿐만 아니라 진료소, 요양시설, 가정 등 특히 노약자나 면역력이 저하된 분들을 돌보는 곳에서도 감염관리는 필수적입니다. 적절한 조치의 부재로 인해 광범위한 감염 확산으로 이어진 최근의 세계 보건 위기는 감염 관리의 중요성을 부각시키고, 엄격하고 효과적인 감염 관리 대책의 필요성을 강조하고 있습니다.
이번 코로나19 사태는 왜 강력한 감염 관리 대책의 필요성을 다시금 일깨워주었을까요?
코로나19 팬데믹은 감염 관리 상황을 극적으로 변화시켰고, 이 분야에 전례 없는 관심과 자원을 가져왔습니다. 전 세계 의료시설은 환자 급증에 대응하고 시설 안팎의 바이러스 확산을 방지하기 위해 감염 관리 프로토콜을 검토하고 업데이트했습니다. 이러한 상황은 UV-C 소독, HEPA 필터, 첨단 개인보호장비(PPE) 등 감염관리 기술의 혁신을 가속화했습니다. 또한, 정부 및 기관에서 의료진에 대한 감염 예방 및 관리 모범 사례 교육에 대한 투자가 증가하고 있으며, 이는 현재 유행하는 전염병뿐만 아니라 향후 발생할 수 있는 전염병에 대응하는 데에도 매우 중요합니다.
감염 관리를 혁신하는 기술 발전이란?
기술은 감염 관리 대책의 발전에 있어 매우 중요한 역할을 하고 있습니다. 새로운 진단 도구의 개발로 병원체의 신속한 식별이 가능해져 효과적인 감염 관리에 필수적인 요소로 자리 잡고 있습니다. 저온 플라즈마 멸균과 같은 첨단 멸균 기술은 독성 화학물질과 고온을 수반하는 기존 방식에 비해 보다 효율적이고 안전한 대안을 제공합니다. 또한, 일부 의료 현장에서는 수작업으로 청소하는 것보다 더 철저하고 일관성 있는 방의 제염과 장비 소독을 위해 로봇 기술이나 자동화 기술도 도입하고 있습니다. 또한, 정보 기술은 감염률과 치료 결과를 모니터링하기 위한 추적 및 데이터 분석을 용이하게 하여 감염 관리 프로그램의 효과를 크게 향상시키고 있습니다.
감염 관리 시장의 성장을 이끄는 주요 요인은 무엇일까요?
감염 관리 시장의 성장은 의료 관련 감염(HAI)에 대한 인식 증가, 살균 및 소독 제품의 기술 발전, 코로나19 팬데믹과 같은 세계 보건 위기 등 여러 요인에 의해 촉진되고 있습니다. 환자 안전의 향상과 엄격한 규제 기준에 대한 대응이 요구됨에 따라 다양한 의료 현장에서 효과적인 감염관리 솔루션에 대한 수요가 증가하고 있습니다. 기술 혁신으로 보다 효과적이고 효율적인 감염 관리 제품이 개발되어 전 세계 의료시설에서 빠르게 도입되고 있습니다. 또한, 의료진과 일반인 모두 위생관리에 대한 인식이 높아지는 등 소비자 행동의 변화도 시장 성장을 더욱 촉진하고 있습니다.
부문:
제품 및 서비스(방호 배리어, 멸균 제품 및 서비스, 세정 및 소독 제품, 내시경 재처리 제품, 기타 제품 및 서비스), 최종 용도(병원 및 진료소, 제약 및 의료기기 기업, 기타 최종 용도)
조사 대상 기업 예
3M Company
AstraZeneca PLC
B. Braun Melsungen AG
Becton, Dickinson and Company
bioMerieux SA
AliMed, Inc.
Baumer SA
Ansell Ltd.
Allegion PLC
Alfred Becht GmbH
Belimed AG
A-dec Inc.
Advanced Sterilization Products
Ahlstrom-Munksjo
ABC Dentistry &Orthodontics
AI 통합
검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.
Market Glass, Inc.는 LLM이나 산업 특화형 SLM을 쿼리하는 일반적인 방식이 아닌, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.
관세 영향 계수
Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하는 가운데, 이번 보고서에서는 지리적 시장에 대한 관세의 영향을 반영하였습니다. 이러한 복잡하고 다면적인 시장 현실은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사들에게 다양한 영향을 미칠 것입니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global Infection Control Market to Reach US$83.4 Billion by 2030
The global market for Infection Control estimated at US$56.3 Billion in the year 2024, is expected to reach US$83.4 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Protective Barriers, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$34.8 Billion by the end of the analysis period. Growth in the Sterilization Products & Services segment is estimated at 7.0% CAGR over the analysis period.
The U.S. Market is Estimated at US$15.3 Billion While China is Forecast to Grow at 8.0% CAGR
The Infection Control market in the U.S. is estimated at US$15.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$12.9 Billion by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.4% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.
Global Infection Control Market - Key Trends & Drivers Summarized
What Defines the Scope and Importance of Infection Control Today?
Infection control is a critical discipline within healthcare that aims to prevent or stop the spread of infections in healthcare facilities and communities. This field encompasses various practices, processes, and procedures used to minimize the risk of infection. It involves the use of disinfection methods, sterilization procedures, and sanitation practices to protect patients and healthcare workers alike. Infection control is essential not only in hospitals but also in other settings such as clinics, nursing homes, and at home, especially when caring for the elderly or those with weakened immune systems. The significance of infection control has been underscored by recent global health crises, where the lack of proper practices led to widespread outbreaks, highlighting the need for stringent and effective infection control measures.
How Have Pandemics Reinforced the Necessity for Robust Infection Control Measures?
The COVID-19 pandemic has dramatically transformed the landscape of infection control, bringing unprecedented attention and resources to this field. Healthcare facilities worldwide have revised and updated their infection control protocols to handle the surge in patients while preventing the spread of the virus within and beyond their walls. This situation has accelerated innovation in infection control technologies, such as UV-C disinfection, HEPA filters, and advanced personal protective equipment (PPE). Moreover, it has led to increased governmental and institutional investments in training healthcare workers in the best practices for infection prevention and control, which is critical in managing not only the current pandemic but also future outbreaks.
Which Technological Innovations Are Revolutionizing Infection Control?
Technology plays a pivotal role in advancing infection control measures. The development of new diagnostic tools has enabled faster identification of pathogens, which is crucial for effective infection control. Advanced sterilization technology, such as low-temperature plasma sterilization, offers more efficient and safer alternatives to traditional methods, which often involved toxic chemicals or high heat. Robotics and automation have also been introduced in some healthcare settings to decontaminate rooms and equipment more thoroughly and consistently than manual cleaning. Furthermore, information technology has facilitated better tracking and data analysis to monitor infection rates and outcomes, significantly enhancing infection control programs' effectiveness.
What Are the Major Drivers of Growth in the Infection Control Market?
The growth in the infection control market is driven by several factors, including increased awareness of healthcare-associated infections (HAIs), technological advancements in sterilization and disinfection products, and global health crises such as the COVID-19 pandemic. There is a growing demand for effective infection control solutions across various healthcare settings, driven by the need to improve patient safety and meet stringent regulatory standards. Technological innovations have led to the development of more effective and efficient infection control products, which are being rapidly adopted by healthcare facilities worldwide. Additionally, shifts in consumer behavior, particularly the increased emphasis on sanitation and hygiene practices observed in both healthcare workers and the general public, are further propelling the market growth.
SCOPE OF STUDY:
The report analyzes the Infection Control market in terms of units by the following Segments, and Geographic Regions/Countries:
World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
Select Competitors (Total 145 Featured) -
3M Company
AstraZeneca PLC
B. Braun Melsungen AG
Becton, Dickinson and Company
bioMerieux SA
AliMed, Inc.
Baumer SA
Ansell Ltd.
Allegion PLC
Alfred Becht GmbH
Belimed AG
A-dec Inc.
Advanced Sterilization Products
Ahlstrom-Munksjo
ABC Dentistry & Orthodontics
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
Infection Control - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
Major Players in the Global Sterilization Equipment Market
Low-Temperature Sterilization Gains Ground
Leading Players in the Low-Temperature Sterilization Market
Emergence of Outsourcing Trend Bodes Well for Sterilization Services
E-beam Sterilization of Medical Devices Registers Rapid Growth
Endoscope Contamination - A Major Health Hazard Driving the Demand for Sterilization Equipment
Increasing Need to Reduce Hospital-Acquired Infections Propel Market Demand
Leading Nosocomial Infections in the US: Percentage Breakdown of Healthcare Cost by Infection Type
Government Support to Ensure Infection Control in Clinical Settings to Boost Demand for Infection Control Products
Increasing Prevalence of Chronic Disorders, Rise in Surgical Procedures and the Need to Prevent Transmission of Infections Fuels Market Growth
Aging Population - A Key Growth Driver
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Rising Demand for Medical Devices Augurs Well for the Market
Surgical Drapes and Gowns: Indispensable for Safe Healthcare
Surgical Gowns Market: Stable Growth Outlook
High Demand for Disposable Drapes and Gowns
Growth in Medical Device Reprocessing to Offer New Areas of Growth
Improving Healthcare Expenditure to Bode Well for Market Growth
Technological Advancements
Sealive's Biovector Sterilization Technology for more Effective Inactivation of Viruses and Microorganisms
Introduction of Business-Friendly Policies and Guidelines Fuel Demand for Eco-Friendly Medical Sterilization Equipment
Challenges and Future Prospects
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Protective Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 2: World Historic Review for Protective Barriers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 3: World 15-Year Perspective for Protective Barriers by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Sterilization Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 5: World Historic Review for Sterilization Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 6: World 15-Year Perspective for Sterilization Products & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Cleaning & Disinfection Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 8: World Historic Review for Cleaning & Disinfection Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 9: World 15-Year Perspective for Cleaning & Disinfection Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Endoscope Reprocessing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 11: World Historic Review for Endoscope Reprocessing Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 12: World 15-Year Perspective for Endoscope Reprocessing Products by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Other Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 14: World Historic Review for Other Products & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 15: World 15-Year Perspective for Other Products & Services by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 17: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 18: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 20: World Historic Review for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 21: World 15-Year Perspective for Pharma & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 24: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 25: World Infection Control Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
TABLE 26: World Recent Past, Current & Future Analysis for Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 30: USA Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 31: USA 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 33: USA Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 34: USA 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
CANADA
TABLE 35: Canada Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 36: Canada Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 37: Canada 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 38: Canada Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 40: Canada 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
JAPAN
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 41: Japan Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 42: Japan Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 43: Japan 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 44: Japan Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 45: Japan Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 46: Japan 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
CHINA
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 47: China Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 48: China Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 49: China 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 50: China Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 51: China Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 52: China 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
EUROPE
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 53: Europe Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 55: Europe 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 56: Europe Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 57: Europe Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 58: Europe 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 59: Europe Recent Past, Current & Future Analysis for Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 60: Europe Historic Review for Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 61: Europe 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
FRANCE
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 62: France Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 63: France Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 64: France 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 65: France Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 66: France Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 67: France 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
GERMANY
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 68: Germany Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 69: Germany Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 70: Germany 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 71: Germany Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 72: Germany Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 73: Germany 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
ITALY
TABLE 74: Italy Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 75: Italy Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 76: Italy 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 77: Italy Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 78: Italy Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 79: Italy 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
UNITED KINGDOM
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 80: UK Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 81: UK Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 82: UK 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 83: UK Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 84: UK Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 85: UK 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
SPAIN
TABLE 86: Spain Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 87: Spain Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 88: Spain 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 89: Spain Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 90: Spain Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 91: Spain 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
RUSSIA
TABLE 92: Russia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 93: Russia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 94: Russia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 95: Russia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 96: Russia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 97: Russia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 99: Rest of Europe Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 100: Rest of Europe 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 102: Rest of Europe Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 103: Rest of Europe 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 105: Asia-Pacific Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 106: Asia-Pacific 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 108: Asia-Pacific Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 109: Asia-Pacific 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 111: Asia-Pacific Historic Review for Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 112: Asia-Pacific 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
AUSTRALIA
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 113: Australia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 114: Australia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 115: Australia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 116: Australia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 117: Australia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 118: Australia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
INDIA
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 119: India Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 120: India Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 121: India 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 122: India Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 123: India Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 124: India 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 125: South Korea Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 126: South Korea Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 127: South Korea 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 128: South Korea Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 129: South Korea Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 130: South Korea 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 132: Rest of Asia-Pacific Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 135: Rest of Asia-Pacific Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
LATIN AMERICA
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 137: Latin America Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 138: Latin America Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 139: Latin America 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 140: Latin America Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 141: Latin America Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 142: Latin America 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 143: Latin America Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 144: Latin America Historic Review for Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 145: Latin America 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
ARGENTINA
TABLE 146: Argentina Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 147: Argentina Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 148: Argentina 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 149: Argentina Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 150: Argentina Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 151: Argentina 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
BRAZIL
TABLE 152: Brazil Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 153: Brazil Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 154: Brazil 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 155: Brazil Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 156: Brazil Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 157: Brazil 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
MEXICO
TABLE 158: Mexico Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 159: Mexico Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 160: Mexico 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 161: Mexico Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 162: Mexico Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 163: Mexico 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 165: Rest of Latin America Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 166: Rest of Latin America 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 168: Rest of Latin America Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 169: Rest of Latin America 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
MIDDLE EAST
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 170: Middle East Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 171: Middle East Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 172: Middle East 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 173: Middle East Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 174: Middle East Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 175: Middle East 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
TABLE 176: Middle East Recent Past, Current & Future Analysis for Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2024 through 2030 and % CAGR
TABLE 177: Middle East Historic Review for Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 178: Middle East 15-Year Perspective for Infection Control by Geographic Region - Percentage Breakdown of Value Revenues for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
IRAN
TABLE 179: Iran Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 180: Iran Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 181: Iran 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 182: Iran Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 183: Iran Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 184: Iran 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
ISRAEL
TABLE 185: Israel Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 186: Israel Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 187: Israel 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 188: Israel Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 189: Israel Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 190: Israel 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 192: Saudi Arabia Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 193: Saudi Arabia 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 195: Saudi Arabia Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 196: Saudi Arabia 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 197: UAE Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 198: UAE Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 199: UAE 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 200: UAE Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 201: UAE Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 202: UAE 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 204: Rest of Middle East Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 205: Rest of Middle East 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 207: Rest of Middle East Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 208: Rest of Middle East 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030
AFRICA
Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 209: Africa Recent Past, Current & Future Analysis for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 210: Africa Historic Review for Infection Control by Products & Services - Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 211: Africa 15-Year Perspective for Infection Control by Products & Services - Percentage Breakdown of Value Revenues for Protective Barriers, Sterilization Products & Services, Cleaning & Disinfection Products, Endoscope Reprocessing Products and Other Products & Services for the Years 2015, 2025 & 2030
TABLE 212: Africa Recent Past, Current & Future Analysis for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2024 through 2030 and % CAGR
TABLE 213: Africa Historic Review for Infection Control by End-Use - Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2015 through 2023 and % CAGR
TABLE 214: Africa 15-Year Perspective for Infection Control by End-Use - Percentage Breakdown of Value Revenues for Hospitals & Clinics, Pharma & Medical Device Companies and Other End-Uses for the Years 2015, 2025 & 2030